Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts
Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts
專家展望：6位分析師眼中的Travere Therapeutics
In the last three months, 6 analysts have published ratings on Travere Therapeutics (NASDAQ:TVTX), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有6位分析師公佈了對Travere Therapeutics（納斯達克股票代碼：TVTX）的評級，提供了從看漲到看跌的不同視角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Travere Therapeutics, revealing an average target of $14.83, a high estimate of $19.00, and a low estimate of $9.00. Witnessing a positive shift, the current average has risen by 4.07% from the previous average price target of $14.25.
分析師爲Travere Therapeutics設定了12個月的目標股價，顯示平均目標股價爲14.83美元，最高估計爲19.00美元，低估值爲9.00美元。當前的平均價格從之前的平均目標價14.25美元上漲了4.07％，這是一個積極的轉變。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析師評級：深度探索
An in-depth analysis of recent...
對分析師近期...
登入免費觀看全文
登入/註冊